nebivolol 5mg tablets
milpharm ltd - nebivolol hydrochloride - oral tablet - 5mg
nebivolol 2.5mg tablets
milpharm ltd - nebivolol hydrochloride - oral tablet - 2.5mg
nebivolol 5mg tablets
glenmark pharmaceuticals europe ltd - nebivolol hydrochloride - oral tablet - 5mg
nebivolol 2.5mg tablets
glenmark pharmaceuticals europe ltd - nebivolol hydrochloride - oral tablet - 2.5mg
nebivolol 5mg tablets
accord-uk ltd - nebivolol hydrochloride - oral tablet - 5mg
nebivolol 5mg tablets
torrent pharma (uk) ltd - nebivolol hydrochloride - oral tablet - 5mg
nebivolol 5mg tablets
sandoz ltd - nebivolol hydrochloride - oral tablet - 5mg
nebivolol scp nebivolol (as hydrochloride) 10 mg immediate release tablet blister pack
southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 10.9 mg (equivalent: nebivolol, qty 10 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.
nebivolol scp nebivolol (as hydrochloride) 5 mg immediate release tablet blister pack
southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.
nebivolol scp nebivolol (as hydrochloride) 2.5 mg immediate release tablet blister pack
southern cross pharma pty ltd - nebivolol hydrochloride, quantity: 2.725 mg (equivalent: nebivolol, qty 2.5 mg) - tablet - excipient ingredients: lactose monohydrate; maize starch; croscarmellose sodium; hypromellose; polysorbate 80; microcrystalline cellulose; silicon dioxide; magnesium stearate - nebivolol is indicated: - to treat essential hypertension; - to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.